Market Place
Sourcing Support
TrueBinding Gets FDA IND for Parkinson’s Ph 2A Trial
18 Nov 2024 //
GLOBENEWSWIRE
TrueBinding raises more than $50M, lays off workers twice in June
07 Jul 2023 //
ENDPTS
TrueBinding Granted Type B End-of-Phase 2 Meeting with FDA for TB006
14 Mar 2023 //
PR NEWSWIRE
TrueBinding Highlights the Potential of TB006’s Unique Mechanism of Action
06 Dec 2022 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.